Skip to main content
Clinical Trials/ISRCTN14376817
ISRCTN14376817
Completed
未知

The evaluation of lung ultrasound as a new diagnostic tool for the assessment of patients following acute coronavirus (COVID-19) infection requiring hospitalisation

Maidstone and Tunbridge Wells NHS Trust0 sites21 target enrollmentJanuary 6, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Post COVID-19 (SARS-CoV-2 infection) imaging surveillance
Sponsor
Maidstone and Tunbridge Wells NHS Trust
Enrollment
21
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Poster results see attached file ISRCTN14376817 COVIDLUSPoster.pdf (added 12/12/2022) 2023 Results article in https://doi.org/10.1016/j.rmed.2023.107176 (added 03/03/2023)

Registry
who.int
Start Date
January 6, 2021
End Date
March 18, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 18\-80 years
  • 2\. Positive sample for SARS\-CoV\-2 (detected by RT\-PCR from a nasopharyngeal swab)
  • 3\. Admitted to hospital due to/with COVID\-19
  • Added 03/03/2021:
  • 4\. Lung infiltrates on chest X\-ray

Exclusion Criteria

  • At baseline:
  • 1\. Unable to mobilise independently
  • 2\. Visually or cognitively impaired
  • 3\. Unable to provide informed consent
  • Added 08/01/2021:
  • 4\. Pregnancy
  • Added 03/03/2021:
  • 5\. Allergy to CT contrast

Outcomes

Primary Outcomes

Not specified

Similar Trials